Pharyngotomy in head and neck squamous cell carcinoma: functional and oncological aspects

被引:5
|
作者
Remmert, Carolin [1 ]
Mansour, Naglaa [1 ]
Hofauer, Benedikt [1 ]
Scherer, Elias Q. [2 ]
Bas, Murat [1 ]
Bier, Henning [1 ]
Knopf, Andreas [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany
[2] Agaples Diakonieklinikum Rotenburg, Dept Otorhinolaryngol Head & Neck Surg, Rotenburg, Wumme, Germany
关键词
Pharyngotomy; head and neck squamous cell carcinoma; outcome; videofluoroscopy; function; QUALITY-OF-LIFE; LATERAL PHARYNGOTOMY; OROPHARYNGEAL CANCER; SURGICAL-TREATMENT; CHEMORADIATION; PRESERVATION; CHEMOTHERAPY; RADIATION; SURVIVAL; SURGERY;
D O I
10.1080/00016489.2017.1355564
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Head and Neck Surgery constantly has to oppose non-invasive organ preservation methods and therefore should be evaluated especially with regard to clinical and functional outcome. We will discuss the role of pharyngotomy in the treatment of HNSCC. Methods: Seventy-three patients with carcinoma of the oral cavity, oro-/hypopharynx and supraglottis underwent lateral/median pharyngotomy. Functional and oncological parameters were retrospectively assessed and set into clinical context. Results: The 5-year recurrence-free-interval (RFI) was significantly higher with surgery and adjuvant radio(chemo) therapy (80%; mean RFI: 92 months) when compared to conservative treatment (68%; mean RFI: 68 months). The 5-year overall-survival (OS) after surgery and conservative treatment was 71% and 54%, respectively. Compared to other surgical techniques (mean RFI: 82 months), pharyngotomy demonstrated a significant higher 5-year RFI (mean RFI: 89 months). Conclusions: Pharyngotomy achieves good exposure and clear resection margins that result in a notably good oncological outcome with a minimum of functional loss. In particular, among UICC IV oropharyngeal HNSCC, pharyngotomy is superior in OS and RFI to conservative methods.
引用
收藏
页码:1281 / 1287
页数:7
相关论文
共 50 条
  • [21] The coagulome of Head and Neck Squamous Cell Carcinoma
    Saidak, Zuzana
    Galmiche, Antoine
    Lottin, Marine
    Montes, Lydia
    Soudet, Simon
    Sevestre, Marie-Antoinette
    Clatot, Florian
    Mirghani, Haitham
    ORAL ONCOLOGY, 2021, 114
  • [22] Exosomes in Head and Neck Squamous Cell Carcinoma
    Xiao, Cheng
    Song, Fang
    Zheng, Yu Long
    Lv, Jiong
    Wang, Qiang Fang
    Xu, Nong
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [23] Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Gurudutt, Vivek V.
    Genden, Eric M.
    JOURNAL OF SKIN CANCER, 2011, 2011
  • [24] MicroRNAs in head and neck squamous cell carcinoma
    Uemura, Mamoru
    Mydlarz, Wojciech
    Chang, Steven
    Hennessey, Patrick
    Sun, Wenyue
    Shao, Chunbo
    Ha, Patric
    Sidransky, David
    Califano, Joseph
    CANCER RESEARCH, 2011, 71
  • [25] Recurrent head and neck squamous cell carcinoma
    Wu, S-Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Squamous cell carcinoma of the head and neck in children
    Dombrowski, Natasha D.
    Wolter, Nikolaus E.
    Irace, Alexandria L.
    Robson, Caroline D.
    Perez-Atayde, Antonio R.
    Mack, Jennifer W.
    Rahbar, Reza
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 117 : 131 - 137
  • [27] Basaloid squamous cell carcinoma of the head and neck
    Paulino, AFG
    Singh, B
    Shah, JP
    Huvos, AG
    LARYNGOSCOPE, 2000, 110 (09): : 1479 - 1482
  • [28] Cutaneous squamous cell carcinoma of the head and neck
    Deutsch, Jochen
    Dippel, Edgar
    Delank, K. -Wolfgang
    LARYNGO-RHINO-OTOLOGIE, 2023, 102 (03) : 186 - 193
  • [29] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Jessica Moskovitz
    Jennifer Moy
    Robert L. Ferris
    Current Oncology Reports, 2018, 20
  • [30] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420